SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity-Reference-Cited by-同舟云学术

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

Published:2013-07-29 Issue:9 Volume:34 Page:1149-1155
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Fang Xing,Guo Lin,Jia Jia,Jin Guo-zhang,Zhao Bin,Zheng Yong-yong,Li Jian-qi,Zhang Ao,Zhen Xue-chu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps201366.pdf

Reference36 articles.

1. Belmaker RH, Agam G . Major depressive disorder. N Engl J Med 2008; 358: 55–68.

2. Duman RS . Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci 2009; 11: 239–55.

3. Millan MJ . The role of monoamines in the actions of established and “novel” antidepressant agents: a critical review. Eur J Pharmacol 2004; 500: 371–84.

4. Kulkarni SK, Dhir A . Current investigational drugs for major depression. Expert Opin Investig Drugs 2009; 18: 767–88.

5. Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS . “Broad spectrum” antidepressants: is more better for the treatment of depression? Life Sci 2003; 73: 3175–9.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis;Signal Transduction and Targeted Therapy;2023-09-18

2. Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review;Pharmaceuticals;2023-03-08

3. Involvement of the dopamine D1 receptor system in the anxiolytic effect of cedrol in the elevated plus maze and light–dark box tests;Journal of Pharmacological Sciences;2020-01

4. Allosteric Modulators of Sigma-1 Receptor: A Review;Frontiers in Pharmacology;2019-03-19

5. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation;Psychopharmacology;2017-10-20